Cargando…
Potential Treatment Strategies for Hepatocellular Carcinoma Cell Sensitization to Sorafenib
Liver cancer is highly malignant, has a low sensitivity to chemotherapy, and is associated with poor patient prognosis. The last 3 years have seen the emergence of promising targeted therapies for the treatment of hepatocellular carcinoma (HCC). For over 10 years, before the discovery of lenvatinib,...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Dove
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9939808/ https://www.ncbi.nlm.nih.gov/pubmed/36815094 http://dx.doi.org/10.2147/JHC.S396231 |